
Torrent Pharmaceuticals Ltd. is Rated Buy
2026-05-06 10:10:40Torrent Pharmaceuticals Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 23 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Surge in Open Interest Signals Bullish Momentum for Torrent Pharmaceuticals Ltd.
2026-04-29 15:00:08Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest (OI) in its derivatives segment, doubling from 12,223 to 24,702 contracts, signalling a significant shift in market positioning. This spike, coupled with robust volume and price action, suggests investors are increasingly optimistic about the stock’s near-term prospects amid a strong sectoral backdrop.
Read full news article
Torrent Pharmaceuticals Sees Sharp Open Interest Surge Signalling Bullish Market Positioning
2026-04-29 14:00:06Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest in its derivatives segment, doubling from 12,223 to 24,737 contracts, signalling a significant shift in market positioning. This spike, coupled with robust volume and price action, suggests growing bullish sentiment among traders and investors in the pharmaceutical sector.
Read full news article
Torrent Pharmaceuticals Sees Sharp Open Interest Surge Signalling Bullish Market Positioning
2026-04-29 13:00:07Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest in its derivatives segment, doubling from 12,223 to 24,657 contracts, signalling a significant shift in market positioning. This spike, coupled with robust volume and price action, suggests renewed investor confidence and potential directional bets on the pharmaceutical giant’s near-term prospects.
Read full news article
Surge in Open Interest Signals Renewed Optimism for Torrent Pharmaceuticals Ltd.
2026-04-29 12:00:06Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest in its derivatives segment, doubling from 12,223 to 24,613 contracts, signalling a significant shift in market positioning. This spike, coupled with robust volume and price action, suggests renewed investor confidence and potential directional bets on the stock’s near-term trajectory.
Read full news article
Surge in Open Interest Signals Renewed Investor Confidence in Torrent Pharmaceuticals Ltd.
2026-04-29 11:00:06Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest in its derivatives segment, doubling from 12,223 to 24,594 contracts, reflecting a 101.2% increase. This sudden spike, coupled with robust volume and price action near its 52-week high, suggests heightened market interest and potential directional bets by investors in the pharmaceutical sector.
Read full news article
Torrent Pharmaceuticals Sees Sharp Open Interest Surge Signalling Bullish Market Positioning
2026-04-29 10:00:06Torrent Pharmaceuticals Ltd. has witnessed a remarkable surge in open interest in its derivatives segment, nearly doubling from 12,223 to 24,437 contracts. This sharp increase, coupled with robust volume and price action, suggests a significant shift in market positioning and renewed bullish sentiment among investors.
Read full news article
Surge in Open Interest Signals Renewed Optimism for Torrent Pharmaceuticals Ltd.
2026-04-27 15:00:11Torrent Pharmaceuticals Ltd. has witnessed a notable surge in open interest in its derivatives segment, reflecting increased market participation and a potential shift in investor sentiment. The stock’s recent price action, combined with rising volumes and improved technical indicators, suggests a growing bullish bias among traders and institutional players alike.
Read full news article
Surge in Open Interest Signals Renewed Optimism in Torrent Pharmaceuticals Ltd.
2026-04-27 14:00:08Torrent Pharmaceuticals Ltd. has witnessed a notable surge in open interest (OI) in its derivatives segment, reflecting a shift in market positioning and investor sentiment. The stock’s recent price action, coupled with increased volumes and a positive upgrade in its Mojo Grade, suggests growing confidence among traders and investors in the pharmaceutical giant’s near-term prospects.
Read full news articleShareholder Meeting / Postal Ballot-Scrutinizers Report
28-Apr-2026 | Source : BSEDeclaration of Voting Results and Scrutinizers Report of NCLT convened Meeting of Equity Shareholders
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
28-Apr-2026 | Source : BSEProceedings of the NCLT convened meeting of the Equity Shareholders of Company
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
10-Apr-2026 | Source : BSEIntimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015
Corporate Actions
No Upcoming Board Meetings
Torrent Pharmaceuticals Ltd. has declared 580% dividend, ex-date: 18 Feb 26
Torrent Pharmaceuticals Ltd. has announced 5:10 stock split, ex-date: 20 Feb 06
Torrent Pharmaceuticals Ltd. has announced 1:1 bonus issue, ex-date: 08 Jul 22
No Rights history available






